OraSure Technologies Inc (FRA:EP3)
€ 3.62 0.02 (0.56%) Market Cap: 268.40 Mil Enterprise Value: 15.14 Mil PE Ratio: 25.33 PB Ratio: 0.67 GF Score: 70/100

OraSure Technologies Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 02:50PM GMT
Release Date Price: €13.6 (-2.16%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Good morning. This is Dan Brennan. I cover Diagnostics Tools and Pharma Services for UBS. And this is day 3 of the conference. Hopefully, you're enjoying it on the virtual conference, that is. Really pleased to be joined with me here on the virtual stage with the senior executive team from OraSure Technologies.

With me on the phone is Steve Tang, President and CEO; and Roberto Cuca. Roberto, if I mispronounce your last name, I apologize, the Chief Financial Officer.

I have a series of questions to go through, but please feel free to log into the webcast and send questions to me that way, and I'll try to get to those.

And I think Steve and Roberto are going to go through a bit of a prepared presentation, which will direct you to the right spot.

But -- with that, let me turn it over to them and say, again, welcome, guys.

Stephen S. Tang
OraSure Technologies, Inc. - President, CEO & Director

Dan,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot